RxDoctor Payments Data

Craig Barker, MD

Family Medicine · Lubbock, TXNPI 1720059611

Payments from drug & device makers

$9,339in general payments, 2019–2025

Across 573 payments — averaging $16.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$1K
  • Pfizer$511
  • Novo Nordisk$498
  • GE HealthCare$445
  • Amgen$351
  • plus $5K from 53 others

What the payments were for

  • Travel & lodging$991%
  • Food & beverage$9,19898%
  • Education$420%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)99$1,489
Lilly USA, LLC97$1,093
Pfizer34$511
Novo Nordisk44$498
GE HealthCare2$445
Amgen24$351
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC19$344
Takeda Pharmaceuticals U.S.A., Inc.21$330
Boehringer Ingelheim18$300
AstraZeneca16$293
Otsuka America Pharmaceutical, Inc.13$286
GSK13$223
Mylan Specialty L.p.12$218
Amarin Pharma, Inc.12$196
Corium, LLC7$157
Exact Sciences8$152
Biohaven Pharmaceutical Holding Company Ltd.14$147
Bayer7$146
Astellas Pharma US Inc7$138
Inspire Medical Systems, Inc.1$115
Merck8$115
Biohaven Pharmaceuticals, Inc.6$99
Lundbeck LLC4$97
Eisai Inc.4$97
Daiichi Sankyo Inc.5$96
Abbott4$82
Radius Health, Inc.5$78
E.r. Squibb & Sons, L.L.C.4$77
Sanofi-aventis U.S. LLC5$76
Supernus Pharmaceuticals, Inc.3$70
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$68
Biogen3$58
Alkermes, Inc.3$56
Acella Pharmaceuticals, LLC3$53
Vanda Pharmaceuticals Inc.2$53
Sunovion Pharmaceuticals Inc.5$52
Johnson & Johnson3$50
Harmony Biosciences LLC2$46
Antares Pharma, Inc.3$43
Sumitomo Pharma America, Inc.2$42
Kowa Pharmaceuticals America, Inc.3$41
Corcept Therapeutics2$41
Mayne Pharma Commercial LLC2$40
Shire North American Group Inc2$39
Dexcom, Inc.2$38
Teva Pharmaceuticals USA, Inc.2$33
Avanir Pharmaceuticals, Inc.2$31
Idorsia Pharmaceuticals US Inc2$30
Ironshore Pharmaceuticals Inc.1$24
Verona Pharma, Inc.1$24
Seqirus USA Inc1$23
Alfasigma USA, Inc.1$22
Insulet Corporation1$19
Redhill Biopharma Inc.1$18
Acadia Pharmaceuticals Inc1$17
Halozyme Inc1$16
Ardelyx, Inc.1$16
Pharmacosmos Therapeutics Inc.1$13
Pacira Therapeutics, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,339 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$106,235
Medicare patients
254
Services billed
13,760

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide111$125,472
MounjaroTirzepatide76$106,088
Trelegy ElliptaFluticasone/Umeclidin/Vilanter60$50,304
LinzessLinaclotide56$43,322
EliquisApixaban46$41,557
RexultiBrexpiprazole13$33,300
TrulicityDulaglutide16$27,510
JanuviaSitagliptin Phosphate16$20,957
JardianceEmpagliflozin24$20,420
XareltoRivaroxaban17$19,797
FarxigaDapagliflozin Propanediol13$18,376
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen459$13,205
Pantoprazole Sodium169$9,435
Dexlansoprazole DrDexlansoprazole33$9,008
Breo ElliptaFluticasone/Vilanterol18$8,608

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,093$133,59892 claims
Novo NordiskOzempic$498$125,472111 claims
GSKTrelegy Ellipta, Breo Ellipta$223$58,91278 claims
AbbVieLinzess, Armour Thyroid$1,489$49,468121 claims
PfizerEliquis, Premarin$511$47,61466 claims
Otsuka America Pharmaceutical, Inc.Rexulti$286$33,30013 claims
Boehringer IngelheimJardiance, Combivent Respimat, Tradjenta$300$33,21751 claims
MerckJanuvia$115$20,95716 claims
Johnson & JohnsonXarelto$50$19,79717 claims
AstraZenecaFarxiga$293$18,37613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Lubbock

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →